Use of Ibuprofen and Similar NSAIDs May Shorten Life of Patients with Metastatic Renal Cell Carcinoma

May 1, 2018 - Amsterdam, NL – Ibuprofen, aspirin, and other non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs’ promising anti-cancer properties have been highlighted by a growing body of data in recent years. However, a new study in the journal Kidney Cancer indicated that non-aspirin NSAID use was associated with shorter overall survival in patients with metastatic renal cell carcinoma (mRCC). More...

May 1, 2018

Journal of Alzheimer’s Disease Marks its 20th Anniversary with a Milestone Issue Covering 20 years of Alzheimer’s Research

Noted experts look back at key advancements that have shaped the field and JAD’s role in the progress that has been achieved

May 1, 2018 - Amsterdam, NL – IOS Press is pleased to announce that 2018 marks the 20th anniversary of the Journal of Alzheimer’s Disease (JAD). One of the many events celebrating this milestone is the publication of an open access issue (JAD 62:3) looking back at 20 years of Alzheimer’s disease (AD) research, which is now available online. More...

May 1, 2018

What if You Could Know That Your Mild Cognitive Impairment Wouldn’t Progress in the Next Decade Through the Result of Two Simple Neuropsychological Tests?

April 24, 2018 - Lisbon, Portugal – Researchers from the Lisbon School of Medicine, University of Lisbon found that, in some mild cognitive impairment patients, real neuropsychological stability over a decade is possible and that long-term stability could be predicted based on neuropsychological tests measuring memory and non-verbal abstract reasoning, according to a study published in the Journal of Alzheimer’s Disease. More...

April 24, 2018

Late, but Not too Late – Screening for Olfactory Dysfunction as a Marker for Cognitive Impairment in Middle-Aged

April 23, 2018 - Essen, Germany – In a large population-based study of randomly selected participants in Germany, researchers found that participants aged 65–74 years with olfactory dysfunction showed impaired cognitive performance. Interestingly, this strong association was not present in younger (55–64 years) or older (75–86 years) participants. Additionally, the effect was more present in women than men. The study was led by Sarah Tebruegge and is published in the Journal of Alzheimer’s Disease. More...

April 23, 2018